Navigation Links
MAP Pharmaceuticals Reports 2007 Fourth Quarter and Year End Financial Results
Date:2/28/2008

to the completion of MAP Pharmaceuticals' initial public offering in October 2007, which generated net proceeds to the company of approximately $62.1 million. In addition, a Series D preferred stock financing was completed in March 2007, raising net proceeds of approximately $50.2 million.

2008 Financial Outlook

MAP Pharmaceuticals' outlook statements are based on current expectations. The following statements are forward looking, and actual results could differ materially depending on market conditions and the factors set forth under "Forward-Looking Statements."

MAP Pharmaceuticals currently expects in fiscal year 2008 to have operating expenses, excluding non-cash share-based compensation and depreciation of approximately $62 to $67 million. For the year ended 2007, MAP Pharmaceuticals had approximately $2.8 million in non-cash share-based compensation and depreciation.

About MAP Pharmaceuticals, Inc.

MAP Pharmaceuticals develops and plans to commercialize new therapies for children and adults who suffer from chronic conditions that it believes are not adequately treated by currently available medicines. The company applies its proprietary inhalation technologies to enhance the therapeutic benefits and commercial attractiveness of proven drugs while minimizing risk by capitalizing on their known safety, efficacy and commercialization history. MAP Pharmaceuticals has two drug candidates, Unit Dose Budesonide and MAP0004, in late stage development for the potential treatment of pediatric asthma and migraine respectively. MAP Pharmaceuticals' pipeline also includes a drug candidate in early clinical development for the treatment of asthma and chronic obstructive pulmonary disease.

Additional information about MAP Pharmaceuticals can be found at http://www.mappharma.com.

Forward-Looking Statements

In addition to statements of historical facts or statements of
'/>"/>

SOURCE MAP Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
2. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
3. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
4. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
5. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
6. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
7. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
8. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
9. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
10. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
11. Class Settlement Could Result in Considerable Savings for Certain Consumers of Prescription Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... Steven Reinberg HealthDay Reporter ... at which cancer cells grow may help doctors diagnose and ... this measure, investigators have found that the deadliest skin cancers ... men with a long history of sun exposure. These ... discovered. Rapid cell growth -- called "high mitotic ...
(Date:8/20/2014)... 20, 2014 Park Cities Pet Sitter ... Presents 4 Pets supply donation drive that benefits the animal ... national campaign that coincides with the Humane Society of the ... 2nd through 8th, 2014. , As part of their participation, ... and monetary donations for the Presents 4 Pets drive from ...
(Date:8/20/2014)... salmon that sprint to spawning grounds through fast-moving waters ... of British Columbia scientists. , When salmon encounter turbulent, ... of dams they must move upstream using a ... sprinting for humans. , "Days after sockeye passed through ... only a short distance from their spawning grounds," said ...
(Date:8/20/2014)... novel approach to treating cancer - using Botox. A ... Science Translational Medicine shows that cancer growth could ... that are linked to cancer stem cells. The approach ... the treatment cheap, safe and efficient. The researchers have ... soon start testing on humans. , The nervous system ...
(Date:8/20/2014)... stimulates stress responses in adults, researchers at Yerkes ... that the amygdala has an inhibitory effect on ... primates. , The results are published this week ... amygdala is a region of the brain known ... and learning about threats. Alterations in the amygdala ...
Breaking Medicine News(10 mins):Health News:High-Risk Melanomas Often on Head or Neck, Study Finds 2Health News:High-Risk Melanomas Often on Head or Neck, Study Finds 3Health News:Dallas-based Park Cities Pet Sitter Announces Participation in the 2014 National Association of Professional Pet Sitters “Presents 4 Pets” Program 2Health News:Dallas-based Park Cities Pet Sitter Announces Participation in the 2014 National Association of Professional Pet Sitters “Presents 4 Pets” Program 3Health News:Dallas-based Park Cities Pet Sitter Announces Participation in the 2014 National Association of Professional Pet Sitters “Presents 4 Pets” Program 4Health News:Salmon forced to 'sprint' less likely to survive migration 2Health News:Treating gastric cancer -- with Botox 2Health News:Maturing brain flips function of amygdala in regulating stress hormones 2Health News:Maturing brain flips function of amygdala in regulating stress hormones 3
... , , , BETHESDA, Md., ... Interactive Patient Care (IPC) solutions, today announced the release of the ... bedside system includes tools focused on accelerating the discharge planning process ... , , "We are excited about ...
... WILMINGTON, Del., July 15 Caregivers of children under ... to determine if their child,s breathing problems are not under ... for Respiratory and Asthma Control in Kids, or TRACK, the ... under five years of age. TRACK helps evaluate respiratory control ...
... LUBBOCK, Texas, July 15 Trends in the economy and ... positions and more temporary assignments. This matches perfectly with an increasing ... their careers. For these reasons and more, Advantage Medical Staffing, ... to their moving to a larger location. , ...
... , FORT LAUDERDALE, Fla. and GRAND PRAIRIE, Texas, July 15 ... Charles Hill has joined the company,s distribution network to help ... , (Logo: http://www.newscom.com/cgi-bin/prnh/20090608/LIVETHESOURCELOGO ... sales expert, Hill will boost li vethesource (TM),s ...
... , , , Go to www.cncb.org ... , DALLAS, July 15 The following information on the CNCB Post Graduate ... , , Session I -Optimal Human Nutrition ... Essential Vitamins , Biochemistry of Essential Minerals , ...
... , , , ... /PRNewswire-USNewswire/ -- TrailBlazer Health Enterprises, LLC ... contract by the federal Centers for Medicare & Medicaid Services ... Jurisdiction 7, which includes Arkansas, Louisiana and Mississippi. The full ...
Cached Medicine News:Health News:GetWellNetwork Introduces Discharge Planning Tools in Latest Version of PatientLife System 2Health News:GetWellNetwork Introduces Discharge Planning Tools in Latest Version of PatientLife System 3Health News:GetWellNetwork Introduces Discharge Planning Tools in Latest Version of PatientLife System 4Health News:New Five-Question Test Helps Assess Asthma Control in Children Under Five Years of Age 2Health News:New Five-Question Test Helps Assess Asthma Control in Children Under Five Years of Age 3Health News:New Five-Question Test Helps Assess Asthma Control in Children Under Five Years of Age 4Health News:Demand for Short-Term Medical Help Leads to Growth for Travel Nursing Staffing Agency; Prompts Move to New Location and Addition of New Online Tools for Nurses 2Health News:livethesource(TM), the World's First and Only Patented, Fully Nano-Encapsulated Liquid Vitamin, Mineral and Herbal Supplement, Now Available in Dallas Area 2Health News:livethesource(TM), the World's First and Only Patented, Fully Nano-Encapsulated Liquid Vitamin, Mineral and Herbal Supplement, Now Available in Dallas Area 3Health News:CNCB Post Graduate Studies in Clinical Nutrition (PGSCN) Program is Now Available Online 2Health News:CMS Selects TrailBlazer Health Enterprises to Administer Medicare Program in Arkansas, Louisiana and Mississippi 2
(Date:8/20/2014)... , Aug. 20, 2014   Ventana Medical ...  Group, today announced that its VENTANA System for ... in the European Union for routine pathology, including ... consisting of VENTANA Virtuoso software coupled with either ... HT slide scanner, provides automated digital slide creation, ...
(Date:8/20/2014)... ApolloDx™ today announced it will unveil and ... event at the company,s office in Salt ... The event, which will start at 10:00 a.m., will ... .    "We believe our mobile diagnostic ... , Co-Founder and Managing Partner of ApolloDx. In addition ...
(Date:8/20/2014)... Trovagene, Inc. (NASDAQ:   TROV), a developer ... two clinical studies will be presented at the 29th ... test for the detection of high risk strains of ... take place in Seattle from ... a new U.S. patent was issued earlier this year ...
Breaking Medicine Technology:Full digitization of the anatomic pathology lab is here with the VENTANA System for Primary Diagnosis 2Full digitization of the anatomic pathology lab is here with the VENTANA System for Primary Diagnosis 3Trovagene Provides Update on Its Urine-Based HPV Test 2Trovagene Provides Update on Its Urine-Based HPV Test 3
... Feb. 15, 2011 Pfenex Inc., an industry ... Technology™ platform and Boehringer Ingelheim International GmbH, a ... contract development and manufacture, announced today that they ... Boehringer Ingelheim with non-exclusive access to the Pfenex ...
... Vermillion, Inc. (Nasdaq: VRML ), a ... to sell 4,000,000 shares of its common stock in ... per share.  The Company expects that the net proceeds ... underwriting discounts and expected offering expenses.  The Company intends ...
Cached Medicine Technology:Pfenex Inc. and Boehringer Ingelheim Announce Non-Exclusive Strategic Agreement for the Use of Pfenex Expression Technology™ 2Pfenex Inc. and Boehringer Ingelheim Announce Non-Exclusive Strategic Agreement for the Use of Pfenex Expression Technology™ 3Vermillion Announces $21.8 Million Public Offering 2Vermillion Announces $21.8 Million Public Offering 3Vermillion Announces $21.8 Million Public Offering 4
Built-in, motor-driven internal calibration mass for convenient Touch-key calibration. Also capable of touch-key calibration with external weights. Built-in RS232 Interface, Shimadzu WindowsDirect ...
... balance. Built-in, motor-driven internal calibration mass ... Automatic Self-Calibration when temperature change detected ... Menu-selected weighing parameters, plug-in peripherals, and ... make this balance series highly accurate ...
60 month warranty; Internal Calibration Mass System Diagnostic to alert operator of abnormal weighing conditions; built-in motorized calibration weight enabling automatic self calibration....
Can download data from your A&D balance directly to your PC saving time and reducing the chances of manually recording the wrong weighing data; 60 month warranty; automatic adjustable environment set...
Medicine Products: